|
HS Code |
957436 |
| Product Name | 1-Boc-4-Methylpiperidine-4-Carboxylic Acid |
| Cas Number | 129753-67-3 |
| Molecular Formula | C12H21NO4 |
| Molecular Weight | 243.3 g/mol |
| Appearance | White to off-white solid |
| Purity | Typically ≥98% |
| Melting Point | 90-94°C |
| Solubility | Soluble in DMSO, methanol, and DMF |
| Storage Conditions | Store at 2-8°C, keep container tightly closed |
| Smiles | CC1(CCN(CC1)C(=O)OC(C)(C)C)C(=O)O |
| Inchi | InChI=1S/C12H21NO4/c1-11(12(14)15)7-9-13(10-8-11)6-16-5-17-4-2-3/h11H,2-10H2,1H3,(H,14,15) |
As an accredited 1-Boc-4-Methylpiperidine-4-Carboxylic Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White HDPE bottle with tamper-evident cap, labeled “1-Boc-4-Methylpiperidine-4-Carboxylic Acid, 25g,” batch number and hazard symbols. |
| Shipping | 1-Boc-4-Methylpiperidine-4-Carboxylic Acid is shipped in tightly sealed containers, protected from light, moisture, and extreme temperatures. Packaging complies with chemical safety regulations. Material Safety Data Sheets (MSDS) and proper labeling ensure secure transit. Standard shipping options are available, with expedited delivery for urgent orders. Handle with care during transport. |
| Storage | Store 1-Boc-4-Methylpiperidine-4-Carboxylic Acid in a tightly sealed container, protected from moisture and light, at room temperature (15–25 °C). Keep in a dry, well-ventilated area away from incompatible substances such as strong acids and bases. Ensure proper labeling, and avoid prolonged exposure to air. Use appropriate personal protective equipment (PPE) when handling the chemical. |
Applications of 1-Boc-4-Methylpiperidine-4-Carboxylic Acid in Industrial ManufacturingAs a direct manufacturer, we supply 1-Boc-4-Methylpiperidine-4-Carboxylic Acid to multiple regulated chemical sectors focused on value-added synthesis. This high-purity intermediate plays a pivotal role in downstream segments where specific molecular modifications, controlled release, and structural integrity are essential to final product performance. Below, we detail distinct industrial manufacturing tracks where this intermediate directly enters high-demand production. 1. Active Pharmaceutical Ingredient (API) Synthesis for CNS MedicationsOur facility supplies this piperidine derivative to pharmaceutical manufacturers specializing in central nervous system (CNS) APIs. The protected amine group enables precise late-stage deprotection, which is crucial when building complex, functionalized CNS-active molecules. Industrial chemists apply it in multi-step synthesis for drug candidates where controlled amine incorporation is required for bioactivity and metabolic stability. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Peptidomimetic Drug DevelopmentPeptidomimetic and peptide-like active compounds often require non-natural amino acid building blocks to improve oral availability, metabolic resistance, and binding specificity. This carboxy-protected piperidine acid serves as a synthetic insert to create backbone-constrained peptides and macrocyclic drugs, delivering the desired conformation without interfering in solid-phase or solution-phase elongation cycles. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Sartan-Class Antihypertensive SynthesisProducers of sartan-class pharmaceutical ingredients, such as those for hypertension management, turn to this raw material as a tuning unit to build substituted biphenyl-tetrazole frameworks. Its inclusion supports specific ring modifications and carboxyl group protection required in the scalable manufacturing route to tetrazole intermediates, ensuring precise introduction points for molecular diversity in medicinal chemistry programs. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. High-Performance Polymer Modifiers for Specialty CoatingsManufacturers in specialty polymer production utilize this compound as a chain terminator or structural modifier in the synthesis of advanced polyamides and functionalized resins. The Boc-protected piperidine unit offers a route to incorporate secondary amine groups while maintaining chemical stability through high-temperature polymerization steps. Subsequent deprotection allows for custom functionalization in surface-modified coatings designed for electronics or automotive components. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
5. Intermediate for Antiviral Drug ManufacturingContract pharmaceutical makers engaged in the development of new antiviral structures require this chemical as a building block for heterocyclic scaffolds with strong metabolic stability and target affinity. The Boc group allows for selective protection during the cyclization or coupling steps in nucleoside analog or protease inhibitor synthesis, providing flexible synthetic options for rapid route scouting in pandemic preparedness projects. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 1-Boc-4-Methylpiperidine-4-Carboxylic Acid prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Producing 1-Boc-4-Methylpiperidine-4-Carboxylic Acid demands deep technical knowledge of both protecting group chemistry and piperidine scaffold handling. Through years working in industrial batch and continuous-flow environments, our team has seen first-hand how this material responds at each stage. The product features a tert-butoxycarbonyl (Boc) group protecting the piperidine nitrogen, paired with a methyl group and a carboxylic acid at the 4-position. That combination offers routes into more complex molecules and intermediates, which makes it highly valued in pharmaceutical and fine chemical syntheses.
Our process involves sourcing piperidine derivatives with strict attention to stereochemistry and impurity load. The Boc protection step must be run with precise control of temperature and moisture because the Boc group can hydrolyze or migrate under suboptimal conditions. Simple oversights with reaction atmosphere or solvent purity leave lingering effects in downstream purification. Technicians working with this molecule notice its crystalline nature after precipitation, and our packing lines monitor for clumping, which signals incomplete drying from the rotary evaporator. Often, we balance between scaling the output and sustaining purity levels above 99%, as even small shifts in reaction parameters can promote side-products that complicate recovery.
Most requests for 1-Boc-4-Methylpiperidine-4-Carboxylic Acid come from medicinal chemistry labs looking to build libraries of candidate molecules. The protected piperidine ring integrates smoothly into peptide couplings, urea and sulfonamide linkages, and various cross-coupling reactions. Researchers appreciate having both the carboxylic acid and the protected amine, since this dual functionality reduces the number of steps required to introduce complexity in targeted lead compounds. We have seen strong demand from customers working on CNS-active agents and kinase inhibitors, where both functional groups play key roles.
During consultations, scientists ask about compatibility with Suzuki or Buchwald-Hartwig strategies. Our experience confirms the Boc group survives most cross-coupling conditions, provided the base and temperature ranges sit within established limits. Acid-driven cleavage to reveal the free amine shows good yields using standard TFA protocols. For labs pursuing grams-to-kilos of modified building blocks, the robustness of 1-Boc-4-Methylpiperidine-4-Carboxylic Acid under various conditions translates to noticeable reductions in troubleshooting time.
Technologists often weigh this product against other Boc-protected piperidine carboxylic acids or their methyl-substituted analogs. Unsubstituted piperidine-4-carboxylic acids reflect different reactivity profiles, lacking the electronic effects conferred by the 4-methyl group. That methyl presence marginally increases steric bulk and slightly alters solubility in polar and nonpolar solvents. We track these changes closely, as they impact crystallization during purification and may influence downstream hydrogenation or acylation steps.
Production staff frequently compare orders for 1-Boc-4-Methylpiperidine-4-Carboxylic Acid to similar protected rings, such as 1-Boc-piperidine-4-carboxylic acid or derivatives with different N-protecting groups like Fmoc. Experience shows that Boc remains the most favored because deprotection finishes cleanly and leaves fewer problematic residues during scale-up. Demanding customers from generic API syntheses express preference for this specific molecule because it integrates predictably and cuts out complicated cleanups after deprotection.
We often find the difference between successful and repeatable large-scale production lies in mastering the drying and milling processes post-crystallization. Over-drying can lead to fine, clumpy powder with static issues, making weight measurement and blending difficult. Under-drying leaves traces of solvents, raising concerns in process validation or GMP audit environments. To hit the right target, our batch operators meticulously monitor Karl Fischer titrations and adjust vacuum oven settings in real time.
Managing particle size distribution shapes our supply to analytical and prep-scale laboratories. Analytical chemists request tighter ranges for automated weighing, while process developers may prefer coarser granules for easier handling. Customizing particle form is not trivial; it takes iterative improvements across filtration, transfer, and grinding steps. Through years of collaboration with formulation engineers, we have fine-tuned the workflows so buyers can run the same synthetic step every time without costly re-optimization.
Analysis begins upstream with raw material qualification—every solvent and reagent is mapped for known and unknown contaminants. Finished product testing includes HPLC, GC-MS, NMR, and titration data. Our analytical lab investigates even subtle leftover residues from the Boc protection stage, including traces of isobutylene and di-tert-butyl dicarbonate, because these can pose risks in later coupling steps.
Several customers require certificates showing heavy metal analysis below tight parts-per-million thresholds. Every batch that leaves our plant carries a full analytical dossier, and repeat customers rarely report out-of-specification findings. Labs working on clinical candidates pay close attention to residual solvent content, and we ensure it remains below cut-off standards for popular systems like dichloromethane, THF, or toluene. Over the last three years, we have not seen a regulatory rejection linked to our product quality.
From our warehouse, operators know temperature fluctuations matter. The Boc group shows some lability under acidic or strongly basic environments, but we have not encountered shelf-life failures under dry, ambient storage in double-bagged packaging. Minor caking can occur if storage rooms run at high humidity or have condensation events, so our standard practice involves pre-desiccating storage bins before loading. For shipping to humid climates or developing regions, we will recommend cold-packing and desiccant pouches for shipments expected to sit in customs longer than 10 days.
Short-term exposure to air causes no adverse effects as long as bulk containers stay closed, but we advise users reseal bags quickly after sampling for inventory checks. Operational incidents usually trace back to accidental mixing of bulk powder samples, which can complicate batch traceability. To prevent such events, barcode tracking and sampling logs tie every outgoing sample with the originating production batch and analytical report.
Regulatory expectations are evolving, and customers request more traceability on starting materials and intermediates. We maintain an up-to-date documentation package that includes full batch records and traceability certificates from piperidine suppliers through to shipment of the final product. Auditors visiting our sites can review original process flows, environmental records, and worker safety sheets for every chemical stage involved in manufacturing this molecule.
Greener chemistry principles push us to limit waste in Boc-protection reactions. Our process engineering team has recently piloted approaches to recycle the organic phase after Boc addition, reclaiming over 50% of used solvents without impacting final product quality. Spent acids from deprotection downstream are neutralized and sent to an on-site treatment unit rather than off-site disposal. These changes, while requiring up-front investment, pay off through reduced emissions and compliance insurance across global markets.
Procurement staff constantly evaluate cost structures on key starting materials, including methylpiperidine and Boc-anhydride. Market volatility affects not just pricing but also lead times, so our supply planning includes at least two qualified vendors for each component in major geographic regions. Over the last production year, regional supply disruptions prompted us to develop buffer stock policies and closer integration with shipping partners to maintain delivery reliability.
With current global uncertainty, a stable and local supply of core intermediates helps end users maintain confidence and regulatory compliance. Our customers cite missed production slots as a critical pain point. By building excess capacity into both solvent and reagent stocks, we buffer most spikes in demand, reducing the risk of extended back-orders that interrupt pharmaceutical campaigns.
Teams new to this molecule often contact us for handling, troubleshooting, or scale-up advice. Based on repeated user feedback, we have compiled process notes and tips to avoid common pitfalls with Boc group stability, solubility concerns, and filtration behaviors. For technicians needing to run gram-to-kilo scale reactions, we offer live consultation on Choice of solvents for dissolution, work-up, and pH adjustment strategies. These knowledge exchanges stem from ongoing collaboration, not one-off technical support calls.
One lab working with urea coupling chemistry reported recurring gelation during work-up, traced to excess dicyclohexylcarbodiimide and insufficient cooling. Our production chemists demonstrated modified protocols with better extraction steps. A customer working on a chiral catalyst project adjusted reaction times after reviewing our notes on methyl substituent reactivity. These real-world lessons avoid costly repeats and promote smoother scaling transitions.
Market interest has increased in the development of small-ring heterocycles for drug discovery, so access to derivatives like 1-Boc-4-Methylpiperidine-4-Carboxylic Acid underpins new routes to kinase inhibitors, neuroactive peptides, and advanced intermediates. Firms working beyond the benchtop face challenges in managing impurity profiles and ensuring flexible sourcing, especially under GMP or commercial supply agreements.
Within production settings, the biggest challenges remain controlling batch variability, achieving purity on kilo scales, and maintaining sustainable solvent usage. While automated process control has improved consistency, skilled operators still intervene to address minor deviations in pH, solvent levels, or crystallization temperature—variables that shift as the seasons and humidity change. Operations teams pay close attention to scale-up data, finding “hidden” issues not seen in small bottles but obvious in bulk runs, such as powder caking or microcontaminant retention.
The synthesis and downstream use of molecules like 1-Boc-4-Methylpiperidine-4-Carboxylic Acid are changing as demand grows for rapid iteration in medicinal chemistry. Newer routes based on continuous flow reactors and solvent recycling support greener and safer production, making the supply chain more robust. By focusing on scalable, high-purity production, we’re able to meet shifting regulatory demands and adapt supply for both research and commercialization.
We expect further integration with digital batch tracking and process optimization software to streamline both internal processes and customer support. Our close relationships with leading pharmaceutical and biotech groups reflect the value of shared process experience, ongoing training, and transparent documentation. For every order, our aim is to contribute both practical chemical expertise and reliable access to critical building blocks that accelerate science and innovation.
Bringing 1-Boc-4-Methylpiperidine-4-Carboxylic Acid from lab-scale concepts to industrial output taught us that success hinges on persistent focus at every stage. Reliable sourcing and hands-on process control at scale matter as much as creative chemistry. Customer feedback continually shapes our routines, and today’s focus rests on tightening analytical controls, sharing actionable know-how, and reducing environmental impact. The steady growth in demand for this class of building blocks keeps us moving forward, refining what we do as the industry transforms.